Research Article

Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis

Table 1

Study characteristics and participants.

First author, published yearCountryTrial IDCentersEnrolled periodAllergenNo. of participantsNo. of femalesTotal dosageBooster doseInjection interval (weeks)FU
Active groupPlacebo groupActive groupPlacebo group

Hellkvist, 2018 [29]Sweden2009-016815-3922012 to 2015Birch and grass pollen24/3027/306103000 SQU0436-63w
Hellkvist, 2022 [31]SwedenNCT02679105/NCT0297547932015 and 2016Grass pollen29/2929/319107000/9000/14000 SQU04-78mo
Hjalmarsson, 2022 [30]SwedenNCT0429647422012 to 2014Birch and grass pollen20/2614/28653000 SQU045-7y
Hylander, 2016 [32]Sweden2009-016815-391September 2010 to September 2011Birch and/or grass pollen20/2115/15863000 SQU03-436w
Konradsen, 2020 [13]UKNCT033945081January 1, 2013, and December 31, 2015Birch and/or grass pollen27/3112/13823000/4000 SQU14-592-104w
Park, 2021 [15]KoreaNCT0266575412016 to December 2018D. farinae, D. pteronyssinus, dogs, and cats17/1913/13118NA0448-50w
Patterson, 2016 [33]USANCT019824741December 2013 to February 2014Grass pollen7/78/8NaNa400 PNU/mL048w
Senti, 2012 [38]SwitzerlandNCT007186791August to September 2008Cat dander8/125/88614 μg0443w
Skaarup, 2021 [34]Denmark2012-005227-3312013Grass pollen23/2412/121253000/4000 SQU14144w
Terada, 2020 [35]JapanNA2NAJapanese cedar pollen12/126/68460 JAU04130w
Thompson, 2020 [36]USANA1Mountain cedar allergy season of 2018 to 2019Mountain cedar pollen11/1110/10753 : 2000 w/v0415-19w
Weinfeld, 2020 [39]SwedenNCT042101931Autumn of 2014Birch and/or grass pollen13/13NaNaNa3000/4000 SQU1484w
Witten, 2013 [37]DenmarkNA1NaGrass pollen25/3013/15653000/6000 SQU0235w

ILIT: intralymphatic immunotherapy; FU: follow-up time; SQU: standardized quality units; PNU: protein nitrogen units; JAU: Japanese allergy units; NA: not available.